MYSM1 and prostate carcinoma: Moreover, levels of monoubiquitinylated H2A are dramatically decreased in prostate tumors and MYSM1 is required for the activation of several target genes in prostate cancer cells [1], suggesting MYSM1 expression may serve as a cancer marker.